Skip to main content

Pulmonary Embolism and DVT

  • Chapter
  • First Online:
Handbook of Inpatient Cardiology


This section describes the risk stratification for pulmonary embolism (PE) and the current guidelines for advanced therapies for VTE. Various testing modalities are discussed in stratifying PE, and treatment options for each clinical severity are reviewed. The main treatment for all PE is anticoagulation; however, in cases of massive and submassive PE, additional remedies can include systemic thrombolysis, catheter-directed and percutaneous mechanical thrombectomy. Anticoagulation is also the main treatment for deep vein thrombosis, but catheter-directed therapy and stent placement can also be considered in very symptomatic patients with proximal thrombosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions



Activated partial thromboplastin time


Catheter-directed thrombolysis


Computed tomography pulmonary angiogram


Chronic thromboembolic pulmonary hypertension


Deep vein thrombosis


European Society of Cardiology


Iliofemoral DVT


Low molecular weight heparin


Novel oral anticoagulants


Pulmonary embolism


Percutaneous mechanical thrombectomy


Pre-test probability


Post thrombotic syndrome




Unfractionated heparin


Ventilation perfusion scan


Vitamin K antagonists


Venous thromboembolism


  1. Kearon C, Ageno W, Cannegieter SC, Cosmi B, Geersing G-J, Kyrle PA. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost. 2016;14(7):1480–3.

    Article  CAS  PubMed  Google Scholar 

  2. Lim W, Le Gal G, Bates S, Righini M, Haramati L, Lang E, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism. Blood Adv. 2018;2(22):3226–56.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Perelas A, Dimou A, Saenz A, Rhee JH, Teerapuncharoen K, Rowden A, et al. Incidental findings on computed tomography angiography in patients evaluated for pulmonary embolism. Ann Am Thorac Soc. 2015;12(5):689–95.

    Article  PubMed  Google Scholar 

  4. Stein P, Fowler S, Goodman L, Gottschalk A, Hales C, Hull R, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006;354(22):2317–27.

    Article  CAS  PubMed  Google Scholar 

  5. Jaff M, McMurtry M, Archer S, Cushman M, Goldenberg N, Goldhaber S, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension. Circulation. 2011;123(16):1788–830.

    Article  PubMed  Google Scholar 

  6. Konstantinides S, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033–80.

    Article  CAS  PubMed  Google Scholar 

  7. Vanni S, Jimenez D, Nazerian P, Morello F, Parisi M, Daghini E, et al. Short-term clinical outcome of normotensive patients with acute PE and high plasma lactate. Thorax. 2015;70(4):333–8.

    Article  PubMed  Google Scholar 

  8. Chatterjee S, Chakraborty A, Weinberg I, Kadakia M, Wilensky R, Sardar P, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage. JAMA. 2014;311(23):2414.

    Article  PubMed  Google Scholar 

  9. Corsi F, Lebreton G, Bréchot N, Hekimian G, Nieszkowska A, Trouillet J, et al. Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation. Critical Care. 2017;21(1):76.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014;370(15):1402–11.

    Article  CAS  PubMed  Google Scholar 

  11. Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M. Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” trial). Am J Cardiol. 2013;111(2):273–7.

    Article  PubMed  Google Scholar 

  12. Kearon C, Akl E, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease. Chest. 2016;149(2):315–52.

    Article  PubMed  Google Scholar 

  13. Barco S, Schmidtmann I, Ageno W, Bauersachs RM, Becattini C, Bernardi E, et al. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial. Eur Heart J. 2019;41:509.

    Google Scholar 

  14. Mismetti P, Laporte S, Pellerin O, Ennezat P, Couturaud F, Elias A, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism. JAMA. 2015;313(16):1627.

    Article  PubMed  Google Scholar 

  15. Konstantinides S, Geibel A, Kasper W, Olschewski M, Blümel L, Just H. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation. 1998;97(19):1946–51.

    Article  CAS  PubMed  Google Scholar 

  16. Pengo V, Lensing A, Prins M, Marchiori A, Davidson B, Tiozzo F, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350(22):2257–64.

    Article  CAS  PubMed  Google Scholar 

  17. Douketis J, Crowther M, Foster G, Ginsberg J. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? Am J Med. 2001;110(7):515–9.

    Article  CAS  PubMed  Google Scholar 

  18. Kahn S. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med. 2008;149(10):698.

    Article  PubMed  Google Scholar 

  19. Vedantham S, Goldhaber S, Julian J, Kahn S, Jaff M, Cohen D, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med. 2017;377(23):2240–52.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Stephanie Wang .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wang, S., McDaniel, M. (2020). Pulmonary Embolism and DVT. In: Wells, B., Quintero, P., Southmayd, G. (eds) Handbook of Inpatient Cardiology. Springer, Cham.

Download citation

  • DOI:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-47867-4

  • Online ISBN: 978-3-030-47868-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics